AtriCure B. V.
AtriCure provides innovative technologies for the treatment of Afib and related conditions. The Isolator® Synergy™ Ablation System is approved in the EU for the treatment of atrial fibrillation. AtriCure's AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted.